Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,843,134
-
Share change
-
+46,109
-
Total reported value
-
$604,074,637
-
Price per share
-
$24.31
-
Number of holders
-
136
-
Value change
-
+$1,543,376
-
Number of buys
-
89
-
Number of sells
-
52
Institutional Holders of SAGENT PHARMACEUTICALS INC - COM (SGNT) as of Q2 2015
As of 30 Jun 2015,
SAGENT PHARMACEUTICALS INC - COM (SGNT) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,843,134 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, BlackRock Fund Advisors, VANGUARD GROUP INC, PENN CAPITAL MANAGEMENT CO INC, STATE STREET CORP, Ranger Investment Management, L.P., HealthCor Management, L.P., ACADIAN ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, and DIMENSIONAL FUND ADVISORS LP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.